Subscribe to ExpertReview

The latest research, meeting updates and CME, in your inbox.

Hong Kong · Sponsored

Advancement in mCRC Management: 2022 Review

31 Jul 2023Oncology

Jeffrey Martin

Share

This content is sponsored. It is intended for healthcare professionals only.

In a webinar held on 14 December 2022, Professor Iain Bee Huat Tan, Professor Jayesh Desai and Dr Ka On Lam presented insights from major international meetings on state-of-the-art metastatic colorectal cancer (mCRC) management.

Advancement in mCRC Management: 2022 Review

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Log inRegister

Related posts

Stylized illustration of a large blue immune cell with surface receptors and yellow nuclei, surrounded by smaller cells.Research · OncologyESCAT v2 adds graded certainty tiers and a resistance scale for molecular targetsAn international ESMO expert panel has revised the 2018 ESCAT framework, restructuring Tier I, Tier II and Tier X, formalising tumour-agnostic gating criteria and adding a four-level scale for resistance biomarkers.8 Nov 2026